Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Applied DNA Sciences, Inc. - Common Stock (NQ: APDN )

0.8620 +0.0020 (+0.23%)
Streaming Delayed Price Updated: 4:00 PM EDT, Apr 24, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Applied DNA Sciences, Inc. - Common Stock

< Previous 1 2
...
5 6 7 8 9 10 11 12 Next >
Stocks That Hit 52-Week Lows On Friday
  During Friday's session, 61 companies made new 52-week lows. 
Via Benzinga
Applied DNA Biotherapeutics Subsidiary LineaRx to Present Data Showcasing Advantages of its Enzymatically Produced LinearDNA as Substitute for Plasmid DNA in IVT mRNA Production at the 2nd Annual mRNA-Based Therapeutics Summit
From Applied DNA Sciences, Inc.
Via Business Wire
Applied DNA Raises $4.2M Via Registered Direct Offering
Applied DNA Sciences, Inc. (NASDAQ:APDN) a polymerase chai... 
Via Benzinga
Applied DNA Sciences To Raise $4.2M Via Registered Direct Offering
Applied DNA Sciences, Inc. (NASDAQ:APDN), a polymera... 
Via Benzinga
Applied DNA Launches Initiatives to Expand Awareness of LinearDNA™ Platform as an Alternative to Plasmid DNA for Therapeutic Applications, Revamps LineaRx Website
From Applied DNA Sciences, Inc.
Via Business Wire
U.S. Government Guidance Permits DNA Traceability and Isotopic Testing as Evidence under Uyghur Forced Labor Prevention Act
From Applied DNA Sciences, Inc.
Via Business Wire
Earnings Scheduled For February 10, 2022
Companies Reporting Before The Bell • Canada Goose Hldgs (NYSE:GOOS) is projected to report quarterly earnings at $1.46 per share on revenue of $584.49 million. 
Via Benzinga
Stocks That Hit 52-Week Lows On Tuesday
On Tuesday, 87 companies hit new 52-week lows. 
Via Benzinga
Applied DNA and EvviVax Announce Peer-Reviewed Publication of Positive Preclinical Data for LinearDNA™ Platform as a Novel Cancer Vaccine Strategy in the Journal of Experimental & Clinical Cancer Research
From Applied DNA Sciences, Inc.
Via Business Wire
12 Health Care Stocks Moving In Tuesday's After-Market Session
Gainers 
Via Benzinga
Recap: Applied DNA Sciences Q2 Earnings
Applied DNA Sciences (NASDAQ:APDN) reported its Q2 earnings results on Thursday, May 12, 2022 at 04:00 PM. Here's what investors need to know about the announcement. 
Via Benzinga
Applied DNA Reports Second Quarter Fiscal 2022 Financial Results
From Applied DNA Sciences, Inc.
Via Business Wire
Earnings Outlook For Applied DNA Sciences
Applied DNA Sciences (NASDAQ:APDN) is set to give its latest quarterly earnings report on Thursday, 2022-05-12. Here's what investors need to know before the announcement. Analysts estimate that... 
Via Benzinga
Applied DNA Schedules Fiscal 2022 Second Quarter Financial Results Conference Call and Webcast for Thursday, May 12, 2022
From Applied DNA Sciences, Inc.
Via Business Wire
Applied DNA Awarded NYC-Based ‘Return-to-Office’
From Applied DNA Sciences, Inc
Via Business Wire
Applied DNA to Participate in the 2022 Virtual Growth Conference Presented by Maxim Group LLC and Hosted by M-Vest on March 28th – 30th from 9:00 a.m. - 5:00 p.m. EDT
From Applied DNA Sciences, Inc.
Via Business Wire
Applied DNA Executes LOI with Spindle Biotech for Research Collaboration on Simplified High Yield mRNA Production System
From Applied DNA Sciences, Inc. and Spindle Biotech Inc.
Via Business Wire
InvestorNewsBreaks — Applied DNA Sciences Inc. (NASDAQ: APDN) Closes on $4.2M Registered Direct Offering
Via Investor Brand Network
Applied DNA Announces Closing of $4.2 Million Registered Direct Offering
From Applied DNA Sciences, Inc.
Via Business Wire
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Gainers Passage Bio (NASDAQ:PASG) shares moved upwards by 15.5% to $3.95 during Tuesday's pre-market session. The company's market cap stands at $213.3 million.... 
Via Benzinga
Applied DNA Announces Pricing of $4.2 Million Registered Direct Offering
From Applied DNA Sciences, Inc.
Via Business Wire
12 Health Care Stocks Moving In Thursday's After-Market Session
Gainers Creative Medical Tech (NASDAQ:CELZ 
Via Benzinga
Applied DNA and EvviVax Announce Publication of Positive Preclinical Data for LinearDNA™ Platform Approach to Cancer Immunotherapy
From Applied DNA Sciences, Inc.
Via Business Wire
Looking Into Applied DNA Sciences's Return On Capital Employed
Applied DNA Sciences (NASDAQ:APDN) brought in sales totaling $4.17 million during Q1 according to data provided by Benzinga Pro. However, earnings decreased 4.73%, resulting in a loss of $4.72... 
Via Benzinga
78 Biggest Movers From Friday
Gainers Y-mAbs Therapeutics, Inc. (NASDAQ: YMAB) surged 26% to close at $2.24. Y-mAbs reported completion of pre-BLA meeting with the FDA for Omburtamab. China Online Education... 
Via Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
Gainers Avenue Therapeutics (NASDAQ:ATXI... 
Via Benzinga
52 Weeks High And Low Article
On Friday, 106 companies reached new 52-week lows. Things to Consider About Today's 52-Week Lows: Air Products & Chemicals (NYSE:APD) is the largest company... 
Via Benzinga
41 Stocks Moving In Friday's Mid-Day Session
Gainers Modular Medical, Inc. (NASDAQ: MODD) shares climbed 34.5% to $4.99 following its recent uplisting to the Nasdaq Capital Market on Thursday. Kaival Brands Innovations... 
Via Benzinga
Recap: Applied DNA Sciences Q1 Earnings
Applied DNA Sciences (NASDAQ:APDN) reported its Q1 earnings results on Thursday, February 10, 2022 at 04:00 PM. Here's what investors need to know about the announcement. 
Via Benzinga
Applied DNA First Quarter Fiscal 2022 Financial Results Feature Record Quarterly Revenues
From Applied DNA Sciences, Inc.
Via Business Wire
< Previous 1 2
...
5 6 7 8 9 10 11 12 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.